세계의 유전자 분석 시장 : 기술, 용도, 최종 사용자, 제품 유형, 워크플로우별 예측(2025-2030년)

The Genetic Analysis Market was valued at USD 10.24 billion in 2023, expected to reach USD 10.94 billion in 2024, and is projected to grow at a CAGR of 6.90%, to USD 16.34 billion by 2030.

Genetic analysis, which encompasses studying DNA, RNA, and proteins to understand genetic structures and functions, has a pivotal role across healthcare, agriculture, and biotechnology sectors, driving innovations in personalized medicine, disease diagnostics, and crop improvement. It serves as a cornerstone in precision medicine, enabling tailored therapeutic approaches based on individual genetic profiles. The necessity of genetic analysis arises from its ability to provide insights into genetic disorders, facilitate drug development, and optimize agricultural outputs, thereby addressing crucial healthcare and food security challenges. The global market for genetic analysis is influenced significantly by technological advancements, the decreasing cost of genome sequencing, and a rising focus on research and development. Emerging markets in genomics are expected to benefit greatly from innovations such as CRISPR technology and next-generation sequencing, offering opportunities for stakeholders to expand their footprints by investing in these high-growth areas. However, the market faces challenges such as ethical concerns, data privacy issues, and the high complexity of genetic data which can hinder widespread adoption. Additionally, stringent regulatory frameworks and a lack of standardized protocols pose obstacles to market growth. Despite these challenges, there are substantial opportunities for business expansion through collaborations with research institutions and healthcare providers, aimed at developing comprehensive genetic databases and analytics platforms. Innovation areas with vast potential include bioinformatics, personalized gene therapies, and synthetic biology, which promise to catalyze breakthroughs in disease prevention and intervention strategies. Market players should focus on leveraging AI and machine learning for data analysis to refine predictive models in genomics. To maximize growth prospects, companies should navigate the regulatory landscape proactively, ensuring compliance and addressing ethical concerns related to genetic data usage. By focusing on these strategic priorities, businesses can harness the transformative power of genetic analysis in shaping future healthcare and agricultural paradigms.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Genetic Analysis Market

The Genetic Analysis Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Expanding role of genetic analysis in personalized healthcare and targeted therapies
  • Government initiatives and funding support for genomic research and public health programs
  • Collaboration between academic institutions and biotech companies fostering genetic research
  • Increasing consumer interest in direct-to-consumer genetic testing services for ancestry and health insights
• Market Restraints
  • Growing concerns regarding the variability and accuracy of genetic testing results
  • Barriers to market entry due to rapid technological advancement and intense competition among key players
• Market Opportunities
  • Expansion of genetic testing applications in agriculture for crop improvement and pest resistance
  • Development of genetic analysis tools for drug discovery and personalized treatment plans
  • Utilization of genetic insights for precision farming and sustainable agricultural practices
• Market Challenges
  • Integration complexities of genetic analysis with existing healthcare systems and data interoperability issues
  • Limited expertise and workforce in the field of genetic analysis impacting market growth

Porter's Five Forces: A Strategic Tool for Navigating the Genetic Analysis Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Genetic Analysis Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Genetic Analysis Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Genetic Analysis Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Genetic Analysis Market

A detailed market share analysis in the Genetic Analysis Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Genetic Analysis Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Genetic Analysis Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Genetic Analysis Market

A strategic analysis of the Genetic Analysis Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Genetic Analysis Market, highlighting leading vendors and their innovative profiles. These include 23andMe, Inc., Adaptive Biotechnologies Corporation, Agilent Technologies, Inc., Beckman Coulter, Inc., BGI Group, Bio-Rad Laboratories, Inc., Eurofins Scientific, F. Hoffmann-La Roche Ltd., Genewiz, Inc., Genomic Health, Inc., Guardant Health, Inc., Illumina, Inc., Invitae Corporation, Myriad Genetics, Inc., Oxford Nanopore Technologies plc, Pacific Biosciences of California, Inc., PerkinElmer, Inc., Personalis, Inc., QIAGEN N.V., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Genetic Analysis Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Technology, market is studied across Capillary Electrophoresis, CRISPR, Mass Spectrometry, Microarray, Next-Generation Sequencing, Polymerase Chain Reaction, Polymerase Chain Reaction (PCR), and Single-Cell Genomics. The Polymerase Chain Reaction (PCR) is further studied across Digital PCR and Real-Time PCR.
• Based on Application, market is studied across Agricultural Genetics, Animal Genetics, Clinical Diagnostics, Forensic Science, Pharmaceutical & Biotechnology, and Research. The Clinical Diagnostics is further studied across Cancer Diagnostics, Genetic Disease Diagnostics, and Infectious Diseases.
• Based on End User, market is studied across Diagnostic Laboratories, Forensic Laboratories, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, and Research Centers & Academic Institutions.
• Based on Product, market is studied across Instruments, Reagents & Consumables, and Software & Services.
• Based on Sample Type, market is studied across Blood, Bone, Saliva, and Tissue.
• Based on Workflow, market is studied across Data Analysis, Pre-Sequencing, and Sequencing.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Expanding role of genetic analysis in personalized healthcare and targeted therapies
    • 5.1.1.2. Government initiatives and funding support for genomic research and public health programs
    • 5.1.1.3. Collaboration between academic institutions and biotech companies fostering genetic research
    • 5.1.1.4. Increasing consumer interest in direct-to-consumer genetic testing services for ancestry and health insights
  • 5.1.2. Restraints
    • 5.1.2.1. Growing concerns regarding the variability and accuracy of genetic testing results
    • 5.1.2.2. Barriers to market entry due to rapid technological advancement and intense competition among key players
  • 5.1.3. Opportunities
    • 5.1.3.1. Expansion of genetic testing applications in agriculture for crop improvement and pest resistance
    • 5.1.3.2. Development of genetic analysis tools for drug discovery and personalized treatment plans
    • 5.1.3.3. Utilization of genetic insights for precision farming and sustainable agricultural practices
  • 5.1.4. Challenges
    • 5.1.4.1. Integration complexities of genetic analysis with existing healthcare systems and data interoperability issues
    • 5.1.4.2. Limited expertise and workforce in the field of genetic analysis impacting market growth
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Genetic Analysis Market, by Technology

• 6.1. Introduction
• 6.2. Capillary Electrophoresis
• 6.3. CRISPR
• 6.4. Mass Spectrometry
• 6.5. Microarray
• 6.6. Next-Generation Sequencing
• 6.7. Polymerase Chain Reaction
• 6.8. Polymerase Chain Reaction (PCR)
  • 6.8.1. Digital PCR
  • 6.8.2. Real-Time PCR
• 6.9. Single-Cell Genomics

7. Genetic Analysis Market, by Application

• 7.1. Introduction
• 7.2. Agricultural Genetics
• 7.3. Animal Genetics
• 7.4. Clinical Diagnostics
  • 7.4.1. Cancer Diagnostics
  • 7.4.2. Genetic Disease Diagnostics
  • 7.4.3. Infectious Diseases
• 7.5. Forensic Science
• 7.6. Pharmaceutical & Biotechnology
• 7.7. Research

8. Genetic Analysis Market, by End User

• 8.1. Introduction
• 8.2. Diagnostic Laboratories
• 8.3. Forensic Laboratories
• 8.4. Hospitals & Clinics
• 8.5. Pharmaceutical & Biotechnology Companies
• 8.6. Research Centers & Academic Institutions

9. Genetic Analysis Market, by Product

• 9.1. Introduction
• 9.2. Instruments
• 9.3. Reagents & Consumables
• 9.4. Software & Services

10. Genetic Analysis Market, by Sample Type

• 10.1. Introduction
• 10.2. Blood
• 10.3. Bone
• 10.4. Saliva
• 10.5. Tissue

11. Genetic Analysis Market, by Workflow

• 11.1. Introduction
• 11.2. Data Analysis
• 11.3. Pre-Sequencing
• 11.4. Sequencing

12. Americas Genetic Analysis Market

• 12.1. Introduction
• 12.2. Argentina
• 12.3. Brazil
• 12.4. Canada
• 12.5. Mexico
• 12.6. United States

13. Asia-Pacific Genetic Analysis Market

• 13.1. Introduction
• 13.2. Australia
• 13.3. China
• 13.4. India
• 13.5. Indonesia
• 13.6. Japan
• 13.7. Malaysia
• 13.8. Philippines
• 13.9. Singapore
• 13.10. South Korea
• 13.11. Taiwan
• 13.12. Thailand
• 13.13. Vietnam

14. Europe, Middle East & Africa Genetic Analysis Market

• 14.1. Introduction
• 14.2. Denmark
• 14.3. Egypt
• 14.4. Finland
• 14.5. France
• 14.6. Germany
• 14.7. Israel
• 14.8. Italy
• 14.9. Netherlands
• 14.10. Nigeria
• 14.11. Norway
• 14.12. Poland
• 14.13. Qatar
• 14.14. Russia
• 14.15. Saudi Arabia
• 14.16. South Africa
• 14.17. Spain
• 14.18. Sweden
• 14.19. Switzerland
• 14.20. Turkey
• 14.21. United Arab Emirates
• 14.22. United Kingdom

15. Competitive Landscape

• 15.1. Market Share Analysis, 2023
• 15.2. FPNV Positioning Matrix, 2023
• 15.3. Competitive Scenario Analysis
• 15.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. 23andMe, Inc.
• 2. Adaptive Biotechnologies Corporation
• 3. Agilent Technologies, Inc.
• 4. Beckman Coulter, Inc.
• 5. BGI Group
• 6. Bio-Rad Laboratories, Inc.
• 7. Eurofins Scientific
• 8. F. Hoffmann-La Roche Ltd.
• 9. Genewiz, Inc.
• 10. Genomic Health, Inc.
• 11. Guardant Health, Inc.
• 12. Illumina, Inc.
• 13. Invitae Corporation
• 14. Myriad Genetics, Inc.
• 15. Oxford Nanopore Technologies plc
• 16. Pacific Biosciences of California, Inc.
• 17. PerkinElmer, Inc.
• 18. Personalis, Inc.
• 19. QIAGEN N.V.
• 20. Thermo Fisher Scientific Inc.